Dominic L. Raco

Cardiology
4510 Medical Center Dr Ste 313
Mckinney,, TX 75069

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

In AF, LAAC was noninferior to NOAC therapy for a composite efficacy outcome and reduced non-procedure-related bleeding at 3 y.

In AF, LAAC was noninferior to NOAC therapy for a composite efficacy outcome and reduced non-procedure-related bleeding at 3 y.

Journal: Annals of internal medicine
Published: July 06, 2026

In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.

In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.

Journal: Annals of internal medicine
Published: July 06, 2026

In asymptomatic severe AS, early TAVR vs. clinical surveillance reduced a composite of death, stroke, or CV hospitalization.

In asymptomatic severe AS, early TAVR vs. clinical surveillance reduced a composite of death, stroke, or CV hospitalization.

Journal: Annals of internal medicine
Published: February 03, 2025

In type 2 MI, the T2-risk score predicted death or MI at 1 y.

In type 2 MI, the T2-risk score predicted death or MI at 1 y.

Journal: Annals of internal medicine
Published: June 02, 2023

In ischemic left ventricular systolic dysfunction, adding PCI to medical therapy did not reduce death or HF hospitalization.

In ischemic left ventricular systolic dysfunction, adding PCI to medical therapy did not reduce death or HF hospitalization.

Journal: Annals of internal medicine
Published: December 05, 2022

In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.

In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.

Journal: Annals of internal medicine
Published: January 21, 2020

In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.

In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.

Journal: Annals of internal medicine
Published: January 21, 2020

After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy.

After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy.

Journal: Annals of internal medicine
Published: December 20, 2017
Showing 1-8 of 8

Last Updated: 09/26/2026